|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/13/20 NeuBase Therapeutics, Inc. 8-K:4 2/9/20 1:40K Toppan Merrill/FA
1/21/11 NeuBase Therapeutics, Inc. 8-K/A:4 1/12/11 1:31K Quality EDGAR So… LLC/FA
1/13/11 NeuBase Therapeutics, Inc. 8-K:4 1/12/11 1:26K Quality EDGAR So… LLC/FA
11/14/05 NeuBase Therapeutics, Inc. 8-K:4 11/10/05 1:6K Child Van Wagon… PLLC/FA
____________ | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. |
|